Strategy Consulting
PWC
Full Credential Description
Celadon Pharmaceuticals Plc faced the challenge of navigating the complexities of being admitted to the AIM (Alternative Investment Market) amidst a challenging global market backdrop. The company required comprehensive support across various workstreams, including audit, reporting, and transaction services, to achieve this significant milestone. RSM provided tailored solutions by delivering expert guidance and support throughout the listing process. Their team was instrumental in ensuring that all aspects of the transaction were handled with professionalism and attention to detail. This included addressing the specific needs of Celadon Pharmaceuticals in a way that aligned with their strategic goals. As a result of RSM's involvement, Celadon Pharmaceuticals successfully achieved its AIM listing, which was a critical step for the company in enhancing its visibility and access to capital. The support from RSM not only facilitated the listing but also strengthened the relationship betwee